Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial

✍ Scribed by Earl, Helena M; Vallier, Anne-Laure; Hiller, Louise; Fenwick, Nicola; Young, Jennie; Iddawela, Mahesh; Abraham, Jean; Hughes-Davies, Luke; Gounaris, Ioannis; McAdam, Karen; Houston, Stephen; Hickish, Tamas; Skene, Anthony; Chan, Stephen; Dean, Susan; Ritchie, Diana; Laing, Robert; Harries, Mark; Gallagher, Christopher; Wishart, Gordon; Dunn, Janet; Provenzano, Elena; Caldas, Carlos

• Book ID: 121428800
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 349 KB
• Volume: 15
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/S1470-2045(13)70554-0